Kilitch Drugs (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on March 25, 2026.
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Kilitch Drugs (India) Limited, at its meeting on March 25, 2026, approved the allotment of 1,74,80,782 bonus equity shares of ₹10 each in the ratio of 1:1 (one bonus share for every one share held). The record date for the bonus issue was fixed as March 24, 2026. As a result, the company's paid-up equity share capital has doubled from ₹17.48 crore (1,74,80,782 shares) to ₹34.96 crore (3,49,61,564 shares). The newly allotted bonus shares will rank pari-passu with the existing fully paid-up equity shares.
Shareholders will receive one additional share for every share they hold as of the record date, effectively doubling their share count. While this increases liquidity and lowers the per-share price proportionally, it does not change the overall value of their holdings. The stock price will typically adjust downward on the ex-bonus date.